Margaret Tawadrous

Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial

H. Bachelez, P.C.M. van de Kerkhof, Robert Strohal et al. · The Lancet · 2015 · 394 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +8

Subgroup Analyses of Maraviroc in Previously Treated R5 HIV-1 Infection

Gerd Fätkenheuer, Mark Nelson, Adriano Lazzarin et al. · New England Journal of Medicine · 2008 · 361 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Maraviroc versus Efavirenz, Both in Combination with Zidovudine‐Lamivudine, for the Treatment of Antiretroviral‐Naive Subjects with CCR5‐Tropic HIV‐1 Infection

David A. Cooper, Jayvant Heera, James Goodrich et al. · The Journal of Infectious Diseases · 2010 · 265 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Clinical Efficacy and Safety of a Novel Antifungal, Fosmanogepix, in Patients with Candidemia Caused by Candida auris <i>:</i> Results from a Phase 2 Trial

José A. Vázquez, Peter G. Pappas, Kenneth D Boffard et al. · Antimicrobial Agents and Chemotherapy · 2023 · 78 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Safety and Efficacy of Ceftazidime–Avibactam in the Treatment of Children ≥3 Months to &lt;18 Years With Complicated Urinary Tract Infection: Results from a Phase 2 Randomized, Controlled Trial

John S. Bradley, Emmanuel Roilides, Helen Broadhurst et al. · The Pediatric Infectious Disease Journal · 2019 · 71 citations · Full text

Pharmacy, Pediatrics, Pharmacotherapy +17